Targeted capsules for the delivery of skin whitening agents in the skin
AssigneesInfinitec Activos S.L., Peptidepharma Nova Sl
InventorsMarisabel Mourelle Mancini, Magdalena Carceller Margeli
Life of this patent
Estimating the term…
Loading patent…
AssigneesInfinitec Activos S.L., Peptidepharma Nova Sl
InventorsMarisabel Mourelle Mancini, Magdalena Carceller Margeli
Estimating the term…
The present invention relates to targeted microcapsules or nanocapsules comprising a skin whitening compound to target melanocytes with a peptide, which is a MC1 receptor agonist, wherein said peptide is coupled to the outer surface of the microcapsule or nanocapsule. It also relates to the use of said microcapsules or nanocapsules for the cosmetic prevention and/or cosmetic treatment of cutaneous dark spots, and to the cosmetic compositions comprising said microcapsules or nanocapsules. The invention also relates to the MC1 receptor agonist peptide coupled to the microcapsule or nanocapsule. The invention also relates to a peptide for use as skin whitening compound.
A microcapsule or nanocapsule comprising a skin whitening compound selected from the group consisting of arbutin, vitamin C, ascorbyl phosphate, niacinamide, dynachondrine, a tyrosinase inhibitor peptide, tretinoin, hydroquinone, kojic acid and esters thereof with fatty acids, azelaic acid, glutathione, cinnamomum subavenium extracts, alpha-hydroxy acids such as lactic acid or glycolic acid, ferulic acid, vitamin E, ellagic acid, Dome grate extracts and mixtures thereof and a peptide of formula (I):
(canceled)
A compound of formula (I)
(canceled)
Method for the cosmetic treatment of cutaneous dark spots wherein microcapsules or nanocapsules as defined in are applied to the area of the skin showing cutaneous dark spots.
A peptide of formula (II):
Dependencies are inferred from the claim text.